Skip to main content

Research and statistics

Skip to results
446 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Reported cases of Legionnaires’ disease in residents of England and Wales with onset of symptoms from 2017 to 2023.

  • Data on the real-world effectiveness and impact of the COVID-19 vaccines.

  • Data on the latest findings relating to antimicrobial resistance in Mycoplasma genitalium from specimens collected in sexual health clinics across England.

  • Reports summarising the activities of the UK's national reference laboratory (NRL) for food microbiology.

  • Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.

  • Risk review and statement on the zoonotic risk avian influenza A(H5N1) clade 2.3.4.4b genotype B3.13 would present to people in contact with infected animals in the UK

  • A rapid evidence summary identifying and assessing evidence related to the incubation and infectious periods of influenza A (H1N1v and H1N2v).

  • This rapid review aims to identify and summarise evidence for the effectiveness of interventions.

  • Summaries of Mycoplasma pneumoniae infection reports from UKHSA and NHS laboratories in England and Wales.

  • Reports presenting annual epidemiological data for HIV in East of England.

  • Reports presenting annual epidemiological data for HIV in north-west England.

  • HIV surveillance data in the UK by demographic characteristics and geographical region.

  • Data on human cases of Mycobacterium bovis (M. bovis) in the UK, from 2000 to 2023.

  • Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2023.

  • Total laboratory-confirmed cases of measles in England and Wales.

  • An examination of the epidemiology of syphilis in England presented by demographic characteristics to illustrate how different groups are affected.

  • Evaluation report on uptake of the measles, mumps and rubella (MMR) vaccine during national and regional MMR catch-up activities in 2023 to 2024 in England.

  • Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.

  • Number of laboratory confirmed cases of parvovirus B19 infection in women aged 15 to 44 years in England.

  • Evaluation of the eleventh year of the Zostavax® shingles vaccination programme in England: financial year 2023 to 2024.